AkzoNobel (AKZOY)
(Delayed Data from OTC)
$21.94 USD
+0.05 (0.23%)
Updated Sep 25, 2024 03:53 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Income Statements
Fiscal Year end for Akzo Nobel NV falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 11,546 | 11,427 | 11,342 | 9,744 | 10,389 |
Cost Of Goods | 6,964 | 7,294 | 6,782 | 5,420 | 5,946 |
Gross Profit | 4,582 | 4,133 | 4,561 | 4,324 | 4,443 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,469 | 3,387 | 3,238 | 3,224 | 3,501 |
Income After Depreciation & Amortization | 1,114 | 746 | 1,323 | 1,100 | 942 |
Non-Operating Income | 29 | 19 | 31 | 29 | 22 |
Interest Expense | 294 | 131 | 46 | 79 | 85 |
Pretax Income | 849 | 634 | 1,307 | 1,050 | 879 |
Income Taxes | 320 | 225 | 291 | 275 | 258 |
Minority Interest | 44 | 27 | 43 | 47 | 43 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 528 | 409 | 1,016 | 774 | 622 |
Extras & Discontinued Operations | -5 | -11 | 7 | -8 | 25 |
Net Income (GAAP) | 478 | 371 | 981 | 720 | 604 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,500 | 1,134 | 1,738 | 1,512 | 1,345 |
Depreciation & Amortization (Cash Flow) | 386 | 388 | 415 | 412 | 403 |
Income After Depreciation & Amortization | 1,114 | 746 | 1,323 | 1,100 | 942 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 511.80 | 524.10 | 555.00 | 574.20 | 589.20 |
Diluted EPS Before Non-Recurring Items | 1.10 | 0.86 | 1.60 | 1.48 | 1.16 |
Diluted Net EPS (GAAP) | 0.93 | 0.71 | 1.76 | 1.25 | 0.94 |
Fiscal Year end for Akzo Nobel NV falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,996.73 | 2,884.84 | 2,721.86 | 2,983.30 | 2,988.79 |
Cost Of Goods | NA | NA | 1,620.65 | 1,762.12 | 1,782.80 |
Gross Profit | NA | NA | 1,101.21 | 1,221.19 | 1,205.98 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 872.40 | 835.89 | 901.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 228.81 | 385.30 | 304.22 |
Non-Operating Income | NA | NA | 7.55 | 8.71 | 5.45 |
Interest Expense | NA | NA | 130.52 | 74.01 | 49.07 |
Pretax Income | NA | NA | 105.84 | 319.99 | 260.61 |
Income Taxes | NA | NA | 51.99 | 104.49 | 115.58 |
Minority Interest | NA | NA | 7.50 | 8.71 | 16.36 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 189.45 | 103.15 | 53.86 | 215.50 | 145.02 |
Extras & Discontinued Operations | 1.08 | -1.09 | -3.25 | -1.09 | 0.00 |
Net Income (GAAP) | 190.53 | 102.06 | 43.10 | 205.71 | 128.67 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 512.10 | 512.73 | 511.80 | 510.81 | 511.80 |
Diluted EPS Before Non-Recurring Items | 0.38 | 0.26 | 0.15 | 0.36 | 0.34 |
Diluted Net EPS (GAAP) | 0.37 | 0.20 | 0.08 | 0.40 | 0.25 |